These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8024745)

  • 1. Albert B. Sabin and the development of oral poliovaccine.
    Horaud F
    Biologicals; 1993 Dec; 21(4):311-6. PubMed ID: 8024745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An historical outline of the development of live poliovaccine and its non-target effects.
    Horaud F
    Dev Biol Stand; 1995; 84():117-22. PubMed ID: 7796943
    [No Abstract]   [Full Text] [Related]  

  • 3. Reminiscences of Albert Sabin and his successful strategy for the development of the live oral poliovirus vaccine.
    Chanock RM
    Proc Assoc Am Physicians; 1996 Mar; 108(2):117-26. PubMed ID: 8705731
    [No Abstract]   [Full Text] [Related]  

  • 4. Albert Sabin and the Coalition to Eliminate Polio from the Americas.
    Hampton L
    Am J Public Health; 2009 Jan; 99(1):34-44. PubMed ID: 19008524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albert B. Sabin.
    Melnick JL; Horaud F
    Biologicals; 1993 Dec; 21(4):297-303. PubMed ID: 8024743
    [No Abstract]   [Full Text] [Related]  

  • 6. Medicine and the media: polio still paralyses (Albert Sabin, Jonas Salk).
    Dixon B
    Br J Hosp Med; 1977 Dec; 18(6):595. PubMed ID: 342023
    [No Abstract]   [Full Text] [Related]  

  • 7. Infectious cDNA, cell receptors and transgenic mice in the study of Sabin's poliovirus vaccines.
    Racaniello VR
    Biologicals; 1993 Dec; 21(4):365-9. PubMed ID: 8024752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication.
    Cáceres VM; Sutter RW
    Clin Infect Dis; 2001 Aug; 33(4):531-41. PubMed ID: 11462191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [History of development of the live poliomyelitis vaccine from Sabin attenuated strains in 1959 and idea of poliomyelitis eradication].
    Lashkevich VA
    Vopr Virusol; 2013; 58(1):4-10. PubMed ID: 23785754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The history of polio vaccination with "Sabin's OPV" 60 years after its introduction in Italy: an unforgivable "delay".
    Orsini D; Valchi L; Minet C; Martini M
    J Prev Med Hyg; 2024 Mar; 65(1):E105-E112. PubMed ID: 38706758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A brief history of polio vaccines.
    Blume S; Geesink I
    Science; 2000 Jun; 288(5471):1593-4. PubMed ID: 10858138
    [No Abstract]   [Full Text] [Related]  

  • 12. On the role of the World Health Organization in the development of Sabin vaccines.
    Magrath D; Reeve P
    Biologicals; 1993 Dec; 21(4):345-8. PubMed ID: 8024749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Sabin live poliovirus vaccination trials in the USSR, 1959.
    Horstmann DM
    Yale J Biol Med; 1991; 64(5):499-512. PubMed ID: 1814062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The battle in Madrid over poliomyelitis vaccines (1963): science, ideology and power in the first mass immunization campaign in Spain].
    Tuells J
    Gac Sanit; 2019; 33(5):480-484. PubMed ID: 30031656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
    Pliaka V; Kyriakopoulou Z; Markoulatos P
    Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures.
    Crainic R; Blondel B; Candréa A; Dufraisse G; Horaud F
    Dev Biol Stand; 1985; 60():343-7. PubMed ID: 2995173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Russian contribution to OPV.
    Agol VI; Drozdov SG
    Biologicals; 1993 Dec; 21(4):321-5. PubMed ID: 8024746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches to the construction of new candidate poliovirus type 3 vaccine strains.
    Almond JW; Stone D; Burke K; Skinner MA; Macadam AJ; Wood D; Ferguson M; Minor PD
    Dev Biol Stand; 1993; 78():161-9; discussion 169-70. PubMed ID: 8388827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioneering figures in medicine: Albert Bruce Sabin--inventor of the oral polio vaccine.
    Smith DR; Leggat PA
    Kurume Med J; 2005; 52(3):111-6. PubMed ID: 16422178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.